IVM
EIGR
InterWest Venture Management’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-560,990
| Closed | -$4.22M | – | 7 |
|
|
2022
Q3 | $4.22M | Hold |
560,990
| – | – | 13.02% | 2 |
|
|
2022
Q2 | $3.53M | Hold |
560,990
| – | – | 6.57% | 5 |
|
|
2022
Q1 | $4.66M | Sell |
560,990
-203,928
| -27% | -$1.69M | 1.78% | 6 |
|
|
2021
Q4 | $3.97M | Hold |
764,918
| – | – | 2.35% | 6 |
|
|
2021
Q3 | $5.11M | Hold |
764,918
| – | – | 2.12% | 6 |
|
|
2021
Q2 | $6.52M | Hold |
764,918
| – | – | 2.06% | 5 |
|
|
2021
Q1 | $6.77M | Hold |
764,918
| – | – | 1.78% | 6 |
|
|
2020
Q4 | $9.4M | Hold |
764,918
| – | – | 1.17% | 6 |
|
|
2020
Q3 | $6.23M | Hold |
764,918
| – | – | 1.8% | 5 |
|
|
2020
Q2 | $7.34M | Hold |
764,918
| – | – | 6.09% | 4 |
|
|
2020
Q1 | $5.2M | Hold |
764,918
| – | – | 5.49% | 4 |
|
|
2019
Q4 | $11.4M | Hold |
764,918
| – | – | 4.91% | 4 |
|
|
2019
Q3 | $7.84M | Hold |
764,918
| – | – | 3.01% | 5 |
|
|
2019
Q2 | $8.11M | Sell |
764,918
-3,367
| -0.4% | -$35.7K | 2.62% | 6 |
|
|
2019
Q1 | $10.7M | Sell |
768,285
-473,583
| -38% | -$6.62M | 9.87% | 5 |
|
|
2018
Q4 | $12.6M | Sell |
1,241,868
-357,724
| -22% | -$3.63M | 17.72% | 3 |
|
|
2018
Q3 | $19.2M | Hold |
1,599,592
| – | – | 9.37% | 4 |
|
|
2018
Q2 | $19.5M | Hold |
1,599,592
| – | – | 8.24% | 5 |
|
|
2018
Q1 | $15.8M | Hold |
1,599,592
| – | – | 6.64% | 5 |
|
|
2017
Q4 | $22.3M | Hold |
1,599,592
| – | – | 7.63% | 3 |
|
|
2017
Q3 | $17.6M | Hold |
1,599,592
| – | – | 4.58% | 5 |
|
|
2017
Q2 | $12.6M | Hold |
1,599,592
| – | – | 2.99% | 5 |
|
|
2017
Q1 | $18.3M | Hold |
1,599,592
| – | – | 3.89% | 5 |
|
|
2016
Q4 | $18.6M | Buy |
+1,599,592
| New | +$18.6M | 4.44% | 5 |
|